Guangdong Hybribio Biotech Co.,Ltd.’s Net Profit Rose 160% in First Half of 2022

Guangdong Hybribio Biotech Co.,Ltd. (广东凯普生物科技股份有限公司) (300639.SZ) reported a net profit of 1.1 billion yuan in the first half of 2022, up 160% year-on-year.

Meanwhile, the company posted 2.8 billion yuan in revenue, up 118.9% year-on-year.

At the end of the reporting period, it had 5.8 billion yuan in total assets and 1.3 billion yuan in total liabilities, with a liability-to-asset ratio of 22.6%.